US · ZTEK
Zentek Ltd.
- Sector
- Healthcare · Medical - Instruments & Supplies
- Headquarters
- Guelph, ON P7B 6M4
- Website
- zentek.com
Price · as of 2025-03-31
$0.51
Market cap 63.47M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $212.70 | +41,720.68% |
| Intrinsic Value(DCF) | $0.60 | +17.97% |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | |||||
| 2012 | $0.26 | ||||
| 2013 | $2.29 | ||||
| 2014 | $2.49 | ||||
| 2015 | $1.35 | ||||
| 2016 | $0.63 | ||||
| 2017 | $0.85 | ||||
| 2018 | $0.42 | ||||
| 2019 | $0.26 | ||||
| 2020 | $0.43 | ||||
| 2021 | $2.23 | ||||
| 2022 | $1.99 | $1,537.18 | $0.05 | $0.00 | $0.00 |
| 2023 | $1.60 | $22.41 | $0.03 | $0.00 | $7.00 |
| 2024 | $1.09 | $23.42 | $0.00 | $0.00 | $4.10 |
| 2025 | $1.49 | $297.14 | $0.00 | $0.00 | $0.00 |
AI valuation
Our deep-learning model estimates Zentek Ltd.'s (ZTEK) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $212.70
- Current price
- $0.51
- AI upside
- +41,720.68%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$0.60
+17.97% upside
Graham-Dodd
—
— upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| ZTEK | Zentek Ltd. | $0.51 | 63.47M | +58,323% | +18% | — | — | -21.35 | 14.54 | 245.72 | -22.99 | — | 14.54 | 22.06% | -1100.37% | -1150.68% | -67.74% | -67.33% | -57.26% | 0.05 | -105.13 | 1.25 | 0.38 | -0.06 | -1667.00% | 282626.00% | 168.00% | -2.93% | -1.80 | -44.07% | 0.00% | 0.00% | 0.00% | -22.39 | -34.21 | 246.36 | 27.27 |
| ALXO | ALX Oncology Holdings Inc… | $2.11 | 114.42M | — | — | — | — | -0.41 | 0.49 | — | 0.42 | — | 0.49 | 0.00% | — | — | -88.91% | -1054.84% | -69.10% | 0.15 | -82.40 | 7.26 | 6.95 | 0.00 | -3102.00% | — | -705.00% | -221.24% | -6.59 | -905.96% | 0.00% | 0.00% | 0.00% | 0.39 | 0.45 | — | -7.15 |
| AMWL | American Well Corporation | $5.70 | 94.35M | +398% | -51% | — | — | -0.89 | 0.36 | 0.34 | 1.30 | — | 0.50 | 53.29% | -42.22% | -38.38% | -35.42% | -147.82% | -25.19% | 0.02 | — | 3.37 | 3.17 | 2.49 | -5706.00% | -198.00% | -5372.00% | -77.57% | -0.90 | -92.64% | 0.00% | 0.00% | 0.00% | 0.88 | 1.41 | -0.37 | -7.90 |
| BYSI | BeyondSpring Inc. | $1.35 | 55.52M | — | — | — | — | -5.97 | -2.02 | — | -7.56 | — | -2.02 | 0.00% | — | — | 37.26% | 22.88% | -37.63% | -0.02 | — | 2.60 | 0.27 | 0.28 | -4815.00% | — | 56.00% | -25.12% | -1.49 | 43.56% | 0.00% | 0.00% | 0.00% | -7.31 | -3.84 | — | -16.03 |
| CRDL | Cardiol Therapeutics Inc. | $1.02 | 113.91M | — | — | — | — | -3.18 | 4.71 | — | -2.15 | -19.96 | 4.71 | 0.00% | — | — | -138.47% | 660.06% | -106.99% | 0.01 | — | 4.52 | 4.41 | 0.76 | 1591.00% | — | -64.00% | -21.53% | -3.58 | 411.05% | 0.00% | 0.00% | 0.00% | -2.14 | -3.43 | — | -1.32 |
| GUTS | Fractyl Health, Inc. Comm… | $0.47 | 33.88M | +4,277% | +19% | — | +4,370% | -0.89 | 2.16 | 660.15 | -0.61 | — | 2.16 | 46.24% | -100570.97% | -73864.52% | 46.32% | -484.68% | -74.55% | 2.20 | — | 3.63 | 3.41 | 0.05 | -1818.00% | -2250.00% | 5582.00% | -109.60% | -3.31 | -348.68% | 0.00% | 0.00% | 562.21% | -0.60 | -0.84 | 606.77 | -7.20 |
| HYFT | MindWalk Holdings Corp. | $1.13 | 52.76M | +1,308% | +315% | — | — | -2.28 | 2.92 | 2.84 | -2.48 | — | 4.82 | 47.31% | -50.47% | -123.30% | -105.08% | -30.71% | -57.90% | 0.57 | -1237.63 | 2.08 | 1.72 | -0.09 | -1262.00% | -203.00% | 2775.00% | -10.44% | -0.71 | -20.45% | 0.00% | 0.00% | 10.84% | -5.85 | -9.96 | 2.95 | -2.17 |
| HYPR | Hyperfine, Inc. | $1.07 | 81.53M | +2,340% | -64% | — | — | -1.74 | 1.45 | 5.51 | -0.80 | — | 1.45 | 45.70% | -335.33% | -315.90% | -61.03% | -410.39% | -53.19% | 0.01 | — | 6.15 | 5.26 | 0.89 | -968.00% | 1684.00% | -813.00% | -55.17% | -4.44 | -371.71% | 0.00% | 0.00% | 0.00% | -0.78 | -0.86 | 2.61 | -3.97 |
| MBOT | Microbot Medical Inc. | $2.41 | 109.82M | — | — | — | — | -1.98 | 6.43 | — | -1.53 | — | 6.43 | 0.00% | — | — | -284.97% | 667.72% | -159.40% | 0.03 | — | 2.37 | 2.35 | 0.26 | -3048.00% | — | 334.00% | -39.02% | -3.59 | 508.44% | 0.00% | 0.00% | 3.38% | -1.49 | -1.96 | — | -21.36 |
| MGX | Metagenomi, Inc. Common S… | $1.52 | 57.07M | +1,047% | +86% | — | — | -0.99 | 0.33 | 1.48 | 1.50 | -6.69 | 0.33 | 100.00% | -170.00% | -149.26% | -34.69% | -676.50% | -22.64% | 0.19 | — | 6.91 | 6.69 | -0.22 | 1484.00% | 1684.00% | 1083.00% | -144.84% | -2.92 | -913.98% | 0.00% | 0.00% | 0.00% | 1.41 | 1.11 | -2.39 | -0.37 |
| QNCX | Quince Therapeutics, Inc. | $0.13 | 7M | — | — | — | — | -1.15 | 2.17 | — | -1.09 | -2.05 | -2.18 | 0.00% | — | — | -98.63% | -409.00% | -38.57% | 0.49 | — | 6.05 | 5.72 | -0.24 | 5595.00% | — | 7430.00% | -49.23% | -4.38 | -229.62% | 0.00% | 0.00% | 0.00% | -0.69 | -1.22 | — | -5.41 |
About Zentek Ltd.
Zentek Ltd. engages in the research and development of graphene and related nanomaterials in Canada. It owns 100% interest in the Albany Graphite project located in Northern Ontario, Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compound. In addition, it develops synthesize graphene, graphene oxide, and graphene quantum dots for applications of graphene. The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021. Zentek Ltd. was incorporated in 2008 and is headquartered in Thunder Bay, Canada.
- CEO
- Mohammed Jiwan
- Employees
- 24
- Beta
- 0.43
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($0.60 ÷ $0.51) − 1 = +17.97% (DCF, example).